Nasopharynx

Primary Site Histology Schema Discriminator 1
C110, C112-C113, C118-C119 8000-8700, 9700-9701
C111 8000-8700, 9700-9701 1

Notes

C110, C112-C113, C118-C119: 8000-8700, 9700-9701 C111 and Schema Discriminator 1: Nasopharynx/PharyngealTonsil: 1 (8000-8700, 9700-9701) C110 Superior wall of nasopharynx C111 Posterior wall of nasopharynx (excluding pharyngeal tonsil) C112 Lateral wall of nasopharynx C113 Anterior wall of nasopharynx C118 Overlapping lesion of nasopharynx C119 Nasopharynx, NOS **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 9 *Nasopharynx*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * C111 and Schema Discriminator 1: Nasopharynx/PharyngealTonsil: 2 (8000-8700, 9700-9701): *Oropharynx (p16-)* and *Oropharynx HPV-Mediated (p16+)* * 8710-8714, 8800-8803, 8810-8905, 8912, 8921, 8932-8934, 8940-8990, 9000-9016, 9030-9043, 9045-9110, 9121-9137, 9141-9230, 9240-9580, 9582: *Soft Tissue Head and Neck* * 8720-8790: *Melanoma Head and Neck* * 8804-8806, 8910, 8920, 8930-8931, 8991, 9020, 9044, 9120, 9231, 9581: *Soft Tissue Other* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* **Note 3:** The Schema Discriminator *Nasopharynx/Pharyngeal Tonsil* is used to discriminate between Posterior wall of nasopharynx (adenoid) and Pharyngeal tonsil which are coded to ICD-O-3 code C111

Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Year of Diagnosis <BLANK> No NAACCR #390 None
Primary Site <BLANK> Yes NAACCR #400 None
Histology <BLANK> Yes NAACCR #522 None
Behavior <BLANK> No NAACCR #523 None
Schema Discriminator 1 <BLANK> Yes NAACCR #3926 All SSDI
Tumor Size Clinical <BLANK> No NAACCR #752 None
Tumor Size Pathological <BLANK> No NAACCR #754 None
Tumor Size Summary 999 No NAACCR #756 None
Regional Nodes Positive 99 No NAACCR #820 None
Regional Nodes Examined 99 No NAACCR #830 None
LVI 9 No NAACCR #1182 None
RX Summ Surgery/Radiation Sequence <BLANK> No NAACCR #1380 None
RX Summ Systemic/Surgery Sequence <BLANK> No NAACCR #1639 None
EOD Primary Tumor 999 Yes NAACCR #772 None
EOD Regional Nodes 999 Yes NAACCR #774 None
EOD Mets 00 Yes NAACCR #776 None
SS2018 <BLANK> No NAACCR #764 None
Grade Clinical 9 No NAACCR #3843 CCCR/Canada
COC
NPCR
SEER
SSDI
Grade Pathological 9 No NAACCR #3844 CCCR/Canada
COC
NPCR
SEER
SSDI
Grade Post Therapy <BLANK> No NAACCR #3845 CCCR/Canada
COC
NPCR
SEER
SSDI
Extranodal Exten H&N Clin 8 No NAACCR #3831 COC SSDI
Extranodal Exten H&N Path X.8 No NAACCR #3832 CCCR/Canada
COC
SEER
SSDI
Lymph Nodes Size of Mets XX.8 No NAACCR #3883 CCCR/Canada
COC
SEER
SSDI

Initial Context

Staging Methods

Expand All | Collapse All

Summary Stage 2018

Start

Additional Context
eod_2018_t = 90
eod_2018_m = 90
eod_2018_n = 90

Next Step

  1. EOD Primary Tumor
  2. ss2018_t

Next Step

  1. EOD Regional Nodes
  2. ss2018_n

Next Step

  1. EOD Mets
  2. ss2018_m

Next Step

  1. Summary Stage
  2. ss2018_derived

End

Outputs

Name Default Value Description NAACCR Item Metadata
Schema ID 00090 NAACCR #3800
None
None
Derived Version {{ctx_alg_version}} None None
Derived Summary Stage 2018 9 NAACCR #762
None
None